Viawealth, LLC Novo Nordisk A S Transaction History
Viawealth, LLC
- $162 Billion
- Q1 2025
A detailed history of Viawealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Viawealth, LLC holds 10,031 shares of NVO stock, worth $687,223. This represents 0.43% of its overall portfolio holdings.
Number of Shares
10,031
Previous 8,276
21.21%
Holding current value
$687,223
Previous $712 Million
2.16%
% of portfolio
0.43%
Previous 0.43%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.29 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.01 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$849 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$844 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$813 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $155B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...